204 related articles for article (PubMed ID: 31301965)
1. The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection.
Trøseid M; Mayerhofer CCK; Broch K; Arora S; Svardal A; Hov JR; Andreassen AK; Gude E; Karason K; Dellgren G; Berge RK; Gullestad L; Aukrust P; Ueland T
J Heart Lung Transplant; 2019 Oct; 38(10):1097-1103. PubMed ID: 31301965
[TBL] [Abstract][Full Text] [Related]
2. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M
Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
[TBL] [Abstract][Full Text] [Related]
3. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.
Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL
J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985
[TBL] [Abstract][Full Text] [Related]
4. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
[TBL] [Abstract][Full Text] [Related]
5. Association of gut-related metabolites with outcome in acute heart failure.
Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Heaney LM; Jones DJL; Ng LL; Suzuki T
Am Heart J; 2021 Apr; 234():71-80. PubMed ID: 33454370
[TBL] [Abstract][Full Text] [Related]
6. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.
Koeth RA; Levison BS; Culley MK; Buffa JA; Wang Z; Gregory JC; Org E; Wu Y; Li L; Smith JD; Tang WHW; DiDonato JA; Lusis AJ; Hazen SL
Cell Metab; 2014 Nov; 20(5):799-812. PubMed ID: 25440057
[TBL] [Abstract][Full Text] [Related]
7. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
8. Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients.
Arora S; Andreassen AK; Karason K; Gustafsson F; Eiskjær H; Bøtker HE; Rådegran G; Gude E; Ioanes D; Solbu D; Dellgren G; Ueland T; Aukrust P; Gullestad L;
Circ Heart Fail; 2018 Sep; 11(9):e004050. PubMed ID: 30354362
[TBL] [Abstract][Full Text] [Related]
9. The microbial gbu gene cluster links cardiovascular disease risk associated with red meat consumption to microbiota L-carnitine catabolism.
Buffa JA; Romano KA; Copeland MF; Cody DB; Zhu W; Galvez R; Fu X; Ward K; Ferrell M; Dai HJ; Skye S; Hu P; Li L; Parlov M; McMillan A; Wei X; Nemet I; Koeth RA; Li XS; Wang Z; Sangwan N; Hajjar AM; Dwidar M; Weeks TL; Bergeron N; Krauss RM; Tang WHW; Rey FE; DiDonato JA; Gogonea V; Gerberick GF; Garcia-Garcia JC; Hazen SL
Nat Microbiol; 2022 Jan; 7(1):73-86. PubMed ID: 34949826
[TBL] [Abstract][Full Text] [Related]
10. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
11. TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism.
Canyelles M; Plaza M; Rotllan N; Llobet D; Julve J; Mojal S; Diaz-Ricart M; Soria JM; Escolà-Gil JC; Tondo M; Blanco-Vaca F; Souto JC
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268516
[TBL] [Abstract][Full Text] [Related]
12. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
[TBL] [Abstract][Full Text] [Related]
13. Neither Trimethylamine-N-Oxide nor Trimethyllysine Is Associated with Atherosclerosis: A Cross-Sectional Study in Older Japanese Adults.
Bhuiya J; Notsu Y; Kobayashi H; Shibly AZ; Sheikh AM; Okazaki R; Yamaguchi K; Nagai A; Nabika T; Abe T; Yamasaki M; Isomura M; Yano S
Nutrients; 2023 Feb; 15(3):. PubMed ID: 36771464
[TBL] [Abstract][Full Text] [Related]
14. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
[TBL] [Abstract][Full Text] [Related]
15. Changes in the concentrations of trimethylamine N-oxide (TMAO) and its precursors in patients with amyotrophic lateral sclerosis.
Chen L; Chen Y; Zhao M; Zheng L; Fan D
Sci Rep; 2020 Sep; 10(1):15198. PubMed ID: 32938991
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
Arora S; Andreassen AK; Andersson B; Gustafsson F; Eiskjaer H; Bøtker HE; Rådegran G; Gude E; Ioanes D; Solbu D; Sigurdardottir V; Dellgren G; Erikstad I; Solberg OG; Ueland T; Aukrust P; Gullestad L;
Am J Transplant; 2015 Jul; 15(7):1967-75. PubMed ID: 25783974
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of an anaerobic pathway for metabolism of l-carnitine-derived γ-butyrobetaine to trimethylamine in human gut bacteria.
Rajakovich LJ; Fu B; Bollenbach M; Balskus EP
Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34362844
[TBL] [Abstract][Full Text] [Related]
18. A Phospholipid-Protein Complex from Antarctic Krill Reduced Plasma Homocysteine Levels and Increased Plasma Trimethylamine-N-Oxide (TMAO) and Carnitine Levels in Male Wistar Rats.
Bjørndal B; Ramsvik MS; Lindquist C; Nordrehaug JE; Bruheim I; Svardal A; Nygård O; Berge RK
Mar Drugs; 2015 Sep; 13(9):5706-21. PubMed ID: 26371012
[TBL] [Abstract][Full Text] [Related]
19. Ruminant meat and milk contain δ-valerobetaine, another precursor of trimethylamine N-oxide (TMAO) like γ-butyrobetaine.
Servillo L; D'Onofrio N; Giovane A; Casale R; Cautela D; Castaldo D; Iannaccone F; Neglia G; Campanile G; Balestrieri ML
Food Chem; 2018 Sep; 260():193-199. PubMed ID: 29699662
[TBL] [Abstract][Full Text] [Related]
20. Determination of trimethylamine-N-oxide in combination with L-carnitine and γ-butyrobetaine in human plasma by UPLC/MS/MS.
Grinberga S; Dambrova M; Latkovskis G; Strele I; Konrade I; Hartmane D; Sevostjanovs E; Liepinsh E; Pugovics O
Biomed Chromatogr; 2015 Nov; 29(11):1670-4. PubMed ID: 25873316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
